Smith & Nephew (LON:SN) Given New GBX 1,250 Price Target at Royal Bank Of Canada

Key Points

• Royal Bank of Canada lowered Smith & Nephew’s price target to GBX 1,250 from GBX 1,350 while maintaining a “sector perform” rating, implying 11.41% potential upside from the prior close.
• Analyst sentiment remains cautious: Smith & Nephew has an average “Hold” rating and an average price target of GBX 1,172.56, based on three Buy and six Hold ratings.
• The stock opened at GBX 1,122, below its 50-day and 200-day moving averages, with a market capitalization of approximately £12.30 billion and a P/E ratio of 40.40.

Smith & Nephew (LON:SN - Get Free Report) had its price objective lowered by stock analysts at Royal Bank Of Canada from GBX 1,350 to GBX 1,250 in a report issued on Thursday,London Stock Exchange reports. The firm currently has a "sector perform" rating on the stock. Royal Bank Of Canada's price target indicates a potential upside of 11.41% from the stock's previous close.

SN has been the topic of a number of other reports. Berenberg Bank reaffirmed a "hold" rating and issued a GBX 13 target price on shares of Smith & Nephew in a research report on Friday, May 1st. Shore Capital Group reaffirmed a "buy" rating and issued a GBX 1,000 price target on shares of Smith & Nephew in a report on Tuesday, July 21st. UBS Group reissued a "neutral" rating and set a GBX 1,300 price objective on shares of Smith & Nephew in a report on Tuesday, May 5th. JPMorgan Chase & Co. cut their target price on shares of Smith & Nephew from GBX 1,438 to GBX 1,290 and set a "neutral" rating on the stock in a research note on Thursday. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating and set a GBX 1,400 price target on shares of Smith & Nephew in a research report on Thursday, July 30th. Three investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, Smith & Nephew has an average rating of "Hold" and an average target price of GBX 1,172.56.

Smith & Nephew Price Performance

LON:SN opened at GBX 1,122 on Thursday. The firm has a fifty day moving average price of GBX 1,135.98 and a 200-day moving average price of GBX 1,194.09. The company has a current ratio of 2.14, a quick ratio of 0.84 and a debt-to-equity ratio of 73.07. The stock has a market cap of £12.30 billion, a PE ratio of 40.40, a P/E/G ratio of 0.46 and a beta of 0.69.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source